These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10448301)

  • 41. Reduced Fhit protein expression in human malignant mesothelioma.
    Pylkkänen L; Wolff H; Stjernvall T; Knuuttila A; Anttila S; Husgafvel-Pursiainen K
    Virchows Arch; 2004 Jan; 444(1):43-8. PubMed ID: 14569398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FHIT alterations in cancerous and non-cancerous cervical epithelium.
    Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
    Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.
    Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS
    Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FHIT mutations in human primary gastric cancer.
    Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
    Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
    Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FHITness and cancer.
    Druck T; Berk L; Huebner K
    Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
    Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
    Geradts J; Fong KM; Zimmerman PV; Minna JD
    Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
    Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
    J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas.
    Ferrer M; López-Borges S; Lazo PA
    Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.
    Menin C; Santacatterina M; Zambon A; Montagna M; Parenti A; Ruol A; D'Andrea E
    Cancer Genet Cytogenet; 2000 May; 119(1):56-61. PubMed ID: 10812172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of FHIT gene alterations in ovarian cancer.
    Buttitta F; Marchetti A; Radi O; Bertacca G; Pellegrini S; Gadducci A; Genazzani AR; Bevilacqua G
    Br J Cancer; 1998 Apr; 77(7):1048-51. PubMed ID: 9569038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
    Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.